{
  "id": 12241484,
  "title": "Why is Option Care Health stock surging today?",
  "url": "https://urgent.news/2026/10/05/why-is-option-care-health-stock-surging-today",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-05T21:43:41.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/why-is-option-care-health-stock-surging-today-93CH-4932982"
  },
  "original_language": "en",
  "account": "Option Care Health's stock experienced a significant surge of 20.8% in after-hours trading following a Financial Times report unveiling advanced discussions between McKesson and Clayton Dubilier & Rice (CD&R) to acquire the infusion services provider in a transaction exceeding $5 billion, including debt. While negotiations are still ongoing and could fall through, an agreement could be announced as early as Tuesday. In the proposed arrangement, CD&R would acquire a 51% controlling stake, while McKesson would retain the remaining 49%, with a clause enabling McKesson to purchase the private equity firm's share at a later date. Michael Cherny, an analyst from Leerink Partners, highlighted the strategic significance of the deal, as it would expand McKesson's influence beyond physician offices and into home and alternate-site infusion care, an area experiencing rapid growth. Despite the broader market showing minimal performance on the day, with the S&P 500 up by only 0.05%, the Dow Jones up by 0.07%, and the Nasdaq up by 0.04%, the stock's rise was entirely attributed to the acquisition report. Prior to the after-hours rally, Option Care shares had been struggling, trading near multi-month lows and below their 52-week high of $36.80. The combination of a credible strategic acquirer, the attractive premium implied by the reported valuation, and the involvement of a prominent private equity firm provided investors compelling reasons to reevaluate the stock sharply higher. However, the gap between the current after-hours price and the announced deal value demonstrates that the market acknowledges the transaction is not yet finalized, as a binding agreement has not been signed.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}